Evaluation of the effect of Lactobacillus ruteri in the treatment of Helicobacter pylori with clarithromycin, pantoprazole and amoxicillin regime
Phase 3
Recruiting
- Conditions
- Helicobacter pylori infection.
- Registration Number
- IRCT20201225049825N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Have Helicobacter pylori
The patient volunteering to participate in the study,
Age 40-75 years
Be a resident of Arak.
Exclusion Criteria
Having a metastatic cancer
Pregnancy
Breastfeeding
History of failure of previous H.PYLORI treatment
Incomplete prescribed treatment regimen
Irregular use of medications and non-adherence to the prescribed treatment regimen
Previous gastrectomy
Suffering from incurable diseases
Patients with IHD
Chronic renal failure
GI bleeding
Malignancy
Concomitant use of tetracycline, quinolone, bisphosphonates, and levothyroxine (drug interaction)
People undergoing chemotherapy
Short Bowel Syndrome
Anemia and neutropenia
fever
History of drug and food allergies
Hypercalcemia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Helicobacter pylori infection using fecal antigen test. Timepoint: At the beginning of the study and 4 weeks after the intervention. Method of measurement: Stool antigen test.
- Secondary Outcome Measures
Name Time Method